Vardhaman Laboratories Ltd

NSE :

BSE: 524796

SECTOR : PHARMACEUTICALS

This stock is currently suspended from BSE

52w high/low	₹0.51 / ₹0
P/E ratio	0
Dividend	0
ROE	-0.72
ROCE	-0.72
Face value	10
Book value	₹4.83Cr
Market capital	₹0.21Cr

Shareholding pattern

What is shareholding pattern? Who are shareholders?

Shareholding pattern represents the percentage of share ownership that different investors are holding in the company. A company can have multiple investors who invest in its shares. These are called as shareholders and there are two major categories of shareholders - promoters and public shareholders.

Promoters are typically the founders and public shareholders could be financial institutes like banks, insurance companies, domestic institutional investors, foreign institutional investors and common public.

Cash flow

What is a cash flow statement?

It is a financial statement that offers aggregate statistics on all cash inflows a business collects from its continuing activities and external sources of investment. It also includes all cash outflows over a specified time paying for company operations and investments.The main components of the CFS are cash from three areas: operating, investing, and financing activities...Read more

Balance Sheet

What is a balance sheet?

A balance sheet is a financial statement that records the assets, liabilities, and equity of a company at a certain point in time and provides a basis for estimating return rates and determining the capital structure. It offers a snapshot of what an entity owns and owes, as well as the sum that shareholders spend.The balance sheet complies with the following accounting equation in which assets on the one side, and liabilities plus shareholders' equity on the other, balance out:

Assets = Liabilities + Shareholder's Equity

This is used to conduct fundamental analysis or the estimation of financial ratios alongside other essential financial statements, such as income statement and statement of cash flows...Read more

Profit and loss

What is a profit and loss statement?

A profit and loss statement is a financial statement that represents the revenues, costs and expenses that the company has incurred during a quater or a fiscal year. It is also sometimes referred to as statement of profit and loss, income statement or statement of operations. This statement basically shows the investors and management whether the company has incurred profits or losses and in which areas.

Key Ratios

P/B

0.11

ROE

-0.72

ROCE

-0.72

Sector PE

45.33

₹4.83Cr

Peer Comparison

Dividends

What are dividends?

Dividend, in financial terms, means a certain amount shared with shareholders of a company or a mutual fund on a regular basis – monthly, quarterly or annually. Read more

Bonuses

What are bonuses?

A bonus issue is an offer given to the existing shareholders of the company to subscribe for additional shares. Instead of increasing the dividend payout, the companies off... Read more

Company News

Sorry, we do not have any data here.

Sector News

Sorry, we do not have any data here.

About Vardhaman Laboratories Ltd

Vardhaman Laboratories Ltd was incorporated on 24th April, 1985 under the Companies Act, 1956, in the State of Maharashtra as Vardhaman Laboratories Private Limited ans subsequently converted into a Public Limited vide Special Resolution dated 15th October, 1993 and obtained a fresh Certificate of Incorporation to change of name on 7th December, 1993 as Vardhaman Laboratories Limited, from the Registrar of Companies Maharashtra, Bombay, Consequent on the conversion of the company from Pvt. Ltd to Public Ltd. At present the Company is engaged in manufacturing varieties of formulations and marketing under the brand name of Samrat gained sizable popularity in the area of Western Maharashtra and Southern part of India. The Company started its operation on a small scale basis and during this time was also in the process of identifying a viable project in the pharmaceutical industry. After a thorough and exhastive study, the project for manufacturing the Bulk Drugs as mentioned aboves was conceived in December 1993. During 1998-99, the company has added new formulation products like Ciprofloxin, Norfioxaoin, Ranitidine, etc. It has also obtained export orders for Cotrimethaxile tablets & Paracetemol Caffeine tablets which has been completed.